share_log

石藥集團:翌日披露報表

CSPC PHARMA: NEXT DAY DISCLOSURE RETURN

Hong Kong Stock Exchange ·  May 3 04:24
Summary by Moomoo AI
石藥集團有限公司於2024年5月3日提交了新的翌日披露報表,披露其已發行股本變動情況。報告顯示,石藥集團在2024年4月16日至4月22日期間購回並註銷了26,628,000股普通股,佔其發行前已發行股份的0.223%。購回後,公司於2024年4月30日的已發行股本為11,922,719,732股,而購回註銷後的結存為11,896,091,732股。此次股份購回行動是根據《香港聯合交易所有限公司證券上市規則》的相關條款進行的。
石藥集團有限公司於2024年5月3日提交了新的翌日披露報表,披露其已發行股本變動情況。報告顯示,石藥集團在2024年4月16日至4月22日期間購回並註銷了26,628,000股普通股,佔其發行前已發行股份的0.223%。購回後,公司於2024年4月30日的已發行股本為11,922,719,732股,而購回註銷後的結存為11,896,091,732股。此次股份購回行動是根據《香港聯合交易所有限公司證券上市規則》的相關條款進行的。
Petrochemical Group Limited filed a new Next Day Disclosure Statement on May 3, 2024, disclosing the changes in its issued share capital. The report shows that the petrochemical group repurchased and cancelled 26,628,000 shares of ordinary shares during the period from 16 April to 22 April 2024, representing 0.223% of the shares issued prior to its issuance. After the repurchase, the issued share capital of the Company as of April 30, 2024 was 11,922,719,732 shares and the repurchase and write-down deposits were 11,896,091,732 shares. This share repurchase was conducted in accordance with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Petrochemical Group Limited filed a new Next Day Disclosure Statement on May 3, 2024, disclosing the changes in its issued share capital. The report shows that the petrochemical group repurchased and cancelled 26,628,000 shares of ordinary shares during the period from 16 April to 22 April 2024, representing 0.223% of the shares issued prior to its issuance. After the repurchase, the issued share capital of the Company as of April 30, 2024 was 11,922,719,732 shares and the repurchase and write-down deposits were 11,896,091,732 shares. This share repurchase was conducted in accordance with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more